Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

Published:2015-01-26 Issue:6 Volume:41 Page:544-563
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Younossi Z. M.¹,Park H.²,Saab S.³,Ahmed A.⁴,Dieterich D.⁵,Gordon S. C.⁶

Affiliation:

1. Department of Medicine; Center for Liver Diseases; Inova Fairfax Hospital; Falls Church VA USA

2. University of Florida College of Pharmacy; Gainesville FL USA

3. Departments of Medicine and Surgery; University of California; Los Angeles CA USA

4. Division of Gastroenterology and Hepatology; Stanford University School of Medicine; Stanford CA USA

5. Division of Liver Diseases; Department of Medicine; The Mount Sinai Hospital; New York NY USA

6. Gastroenterology; Henry Ford Health System; Detroit MI USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13081/fullpdf

Reference73 articles.

1. Estimating future hepatitis C morbidity, mortality, and costs in the United States;Wong;Am J Public Health,2000

2. Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease;Gordon;Aliment Pharmacol Ther,2013

3. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;Meer;JAMA,2012

4. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis;D'Ambrosio;Hepatology,2012

5. Hepatitis C in the United States;Holmberg;N Engl J Med,2013

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019;Value in Health;2024-08

2. Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California;The American Journal of Managed Care;2023-10-20

3. Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients;Liver International;2023-03-08

4. Quercetin: A Functional Food-Flavonoid Incredibly Attenuates Emerging and Re-Emerging Viral Infections through Immunomodulatory Actions;Molecules;2023-01-17

5. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs;American Journal of Preventive Medicine;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3